Eligibility Pre-Screening

Cemiplimab Plus Gemcitabine in Patients With Metastatic Pancreatic Adenocarcinoma

This is a simplified pre-screening tool. Your answers help estimate whether you might qualify, but only the research team can confirm your eligibility. This is not medical advice.

Question 1 of 70%

1.Have you been diagnosed with pancreatic ductal adenocarcinoma confirmed by biopsy or cytology?

Press Y/N or 1/2